adc-20220630
June 30, 2022000177191012月31日假象2022Q200017719102022-01-012022-06-300001771910ADC:ProductRevenueNetMember2022-04-012022-06-30ISO 4217:美元0001771910ADC:ProductRevenueNetMember2021-04-012021-06-300001771910ADC:ProductRevenueNetMember2022-01-012022-06-300001771910ADC:ProductRevenueNetMember2021-01-012021-06-300001771910ADC:許可收入成員2022-04-012022-06-300001771910ADC:許可收入成員2021-04-012021-06-300001771910ADC:許可收入成員2022-01-012022-06-300001771910ADC:許可收入成員2021-01-012021-06-3000017719102022-04-012022-06-3000017719102021-04-012021-06-3000017719102021-01-012021-06-300001771910IFRS-Full:RetainedEarningsMembers2021-04-012021-06-30ISO 4217:美元Xbrli:共享00017719102022-06-3000017719102021-12-310001771910IFRS-Full:IssuedCapitalMembers2022-03-310001771910IFRS-Full:SharePremiumMembers2022-03-310001771910IFRS-FULL:其他保留成員2022-03-310001771910IFRS-Full:財務份額成員2022-03-310001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-03-310001771910IFRS-Full:RetainedEarningsMembers2022-03-3100017719102022-03-310001771910IFRS-Full:RetainedEarningsMembers2022-04-012022-06-300001771910IFRS-FULL:其他保留成員2022-04-012022-06-300001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-04-012022-06-300001771910IFRS-Full:SharePremiumMembers2022-04-012022-06-300001771910IFRS-Full:財務份額成員2022-04-012022-06-300001771910IFRS-Full:IssuedCapitalMembers2022-06-300001771910IFRS-Full:SharePremiumMembers2022-06-300001771910IFRS-FULL:其他保留成員2022-06-300001771910IFRS-Full:財務份額成員2022-06-300001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-06-300001771910IFRS-Full:RetainedEarningsMembers2022-06-300001771910IFRS-Full:IssuedCapitalMembers2021-12-310001771910IFRS-Full:SharePremiumMembers2021-12-310001771910IFRS-FULL:其他保留成員2021-12-310001771910IFRS-Full:財務份額成員2021-12-310001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-12-310001771910IFRS-Full:RetainedEarningsMembers2021-12-310001771910IFRS-Full:RetainedEarningsMembers2022-01-012022-06-300001771910IFRS-FULL:其他保留成員2022-01-012022-06-300001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-01-012022-06-300001771910IFRS-Full:SharePremiumMembers2022-01-012022-06-300001771910IFRS-Full:財務份額成員2022-01-012022-06-300001771910IFRS-Full:IssuedCapitalMembers2022-01-012022-06-300001771910IFRS-Full:IssuedCapitalMembers2021-03-310001771910IFRS-Full:SharePremiumMembers2021-03-310001771910IFRS-FULL:其他保留成員2021-03-310001771910IFRS-Full:財務份額成員2021-03-310001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-03-310001771910IFRS-Full:RetainedEarningsMembers2021-03-3100017719102021-03-310001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-04-012021-06-300001771910IFRS-Full:IssuedCapitalMembers2021-04-012021-06-300001771910IFRS-Full:財務份額成員2021-04-012021-06-300001771910IFRS-Full:SharePremiumMembers2021-04-012021-06-300001771910IFRS-FULL:其他保留成員2021-04-012021-06-300001771910IFRS-Full:IssuedCapitalMembers2021-06-300001771910IFRS-Full:SharePremiumMembers2021-06-300001771910IFRS-FULL:其他保留成員2021-06-300001771910IFRS-Full:財務份額成員2021-06-300001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-06-300001771910IFRS-Full:RetainedEarningsMembers2021-06-3000017719102021-06-300001771910IFRS-Full:IssuedCapitalMembers2020-12-310001771910IFRS-Full:SharePremiumMembers2020-12-310001771910IFRS-FULL:其他保留成員2020-12-310001771910IFRS-Full:財務份額成員2020-12-310001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2020-12-310001771910IFRS-Full:RetainedEarningsMembers2020-12-3100017719102020-12-310001771910IFRS-Full:RetainedEarningsMembers2021-01-012021-06-300001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-01-012021-06-300001771910IFRS-Full:IssuedCapitalMembers2021-01-012021-06-300001771910IFRS-Full:財務份額成員2021-01-012021-06-300001771910IFRS-Full:SharePremiumMembers2021-01-012021-06-300001771910IFRS-FULL:其他保留成員2021-01-012021-06-30ADC:子公司ISO 4217:美元ISO4217:英鎊00017719102021-01-012021-12-31Xbrli:純0001771910IFRS-Full:InterestRateRiskMemberADC:RiskFree InterestRateMember2022-01-012022-06-300001771910IFRS-Full:InterestRateRiskMemberADC:RiskFree InterestRateMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-06-300001771910IFRS-Full:InterestRateRiskMemberADC:ImpliedBondYeldMembers2022-01-012022-06-300001771910IFRS-Full:InterestRateRiskMemberADC:ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-06-300001771910ADC:VolatilityRiskMembers2022-01-012022-06-300001771910ADC:VolatilityRiskMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-06-300001771910IFRS-Full:InterestRateRiskMemberADC:RiskFree InterestRateMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910IFRS-Full:InterestRateRiskMemberADC:ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC:VolatilityRiskMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-3000017719102022-01-182022-01-18ADC:細分市場0001771910ADC:外部成本成員2022-04-012022-06-300001771910ADC:外部成本成員2021-04-012021-06-300001771910ADC:外部成本成員2022-01-012022-06-300001771910ADC:外部成本成員2021-01-012021-06-300001771910ADC:員工擴展成員2022-04-012022-06-300001771910ADC:員工擴展成員2021-04-012021-06-300001771910ADC:員工擴展成員2022-01-012022-06-300001771910ADC:員工擴展成員2021-01-012021-06-300001771910ADC:抗體的製造成員2021-01-012021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2020-05-190001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2020-04-2400017719102021-04-012021-04-300001771910ADC:ZYNLONTAFRDM成員2022-04-012022-06-300001771910ADC:ZYNLONTAFRDM成員2022-01-012022-06-300001771910ADC:DosingOf指定人數成員ADC:MilestonePaymentMember2022-01-012022-06-300001771910Adc:SuccessfulCompletionOfInVivoEfficacyStudiesMemberADC:MilestonePaymentMember2022-01-012022-06-300001771910ADC:許可獲取和抗體ZYNLONTAME成員ADC:MilestonePaymentMember2021-01-012021-06-300001771910ADC:MilestonePaymentMemberAdc:LicenseToUseTechnologyToGenerateAntibodyDrugConjugatesZYNLONTAMember2021-01-012021-06-300001771910ADC:ZYNLONTAME成員2021-01-012021-06-300001771910Adc:LicenseToUseTechnologyToGenerateAntibodyDrugConjugatesZYNLONTA2MemberADC:許可證支付成員2021-01-012021-06-300001771910IFRS-Full:Gross CarryingAmount MemberADC:許可InfiniteLivedMember2021-12-310001771910ADC:內部開發成本成員IFRS-Full:Gross CarryingAmount Member2021-12-310001771910ADC:許可定義實時成員IFRS-Full:Gross CarryingAmount Member2021-12-310001771910IFRS-FULL:計算機軟件成員IFRS-Full:Gross CarryingAmount Member2021-12-310001771910IFRS-Full:Gross CarryingAmount Member2021-12-310001771910IFRS-Full:Gross CarryingAmount MemberADC:許可InfiniteLivedMember2022-01-012022-06-300001771910ADC:內部開發成本成員IFRS-Full:Gross CarryingAmount Member2022-01-012022-06-300001771910ADC:許可定義實時成員IFRS-Full:Gross CarryingAmount Member2022-01-012022-06-300001771910IFRS-FULL:計算機軟件成員IFRS-Full:Gross CarryingAmount Member2022-01-012022-06-300001771910IFRS-Full:Gross CarryingAmount Member2022-01-012022-06-300001771910IFRS-Full:Gross CarryingAmount MemberADC:許可InfiniteLivedMember2022-06-300001771910ADC:內部開發成本成員IFRS-Full:Gross CarryingAmount Member2022-06-300001771910ADC:許可定義實時成員IFRS-Full:Gross CarryingAmount Member2022-06-300001771910IFRS-FULL:計算機軟件成員IFRS-Full:Gross CarryingAmount Member2022-06-300001771910IFRS-Full:Gross CarryingAmount Member2022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC:許可InfiniteLivedMember2021-12-310001771910ADC:內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001771910ADC:許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001771910IFRS-FULL:計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC:許可InfiniteLivedMember2022-01-012022-06-300001771910ADC:內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-06-300001771910ADC:許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-06-300001771910IFRS-FULL:計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC:許可InfiniteLivedMember2022-06-300001771910ADC:內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-06-300001771910ADC:許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-06-300001771910IFRS-FULL:計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-06-300001771910ADC:許可InfiniteLivedMember2022-06-300001771910ADC:內部開發成本成員2022-06-300001771910ADC:許可定義實時成員2022-06-300001771910IFRS-FULL:計算機軟件成員2022-06-300001771910IFRS-Full:Gross CarryingAmount MemberADC:許可InfiniteLivedMember2020-12-310001771910ADC:內部開發成本成員IFRS-Full:Gross CarryingAmount Member2020-12-310001771910ADC:許可定義實時成員IFRS-Full:Gross CarryingAmount Member2020-12-310001771910IFRS-FULL:計算機軟件成員IFRS-Full:Gross CarryingAmount Member2020-12-310001771910IFRS-Full:Gross CarryingAmount Member2020-12-310001771910IFRS-Full:Gross CarryingAmount MemberADC:許可InfiniteLivedMember2021-01-012021-06-300001771910ADC:內部開發成本成員IFRS-Full:Gross CarryingAmount Member2021-01-012021-06-300001771910ADC:許可定義實時成員IFRS-Full:Gross CarryingAmount Member2021-01-012021-06-300001771910IFRS-FULL:計算機軟件成員IFRS-Full:Gross CarryingAmount Member2021-01-012021-06-300001771910IFRS-Full:Gross CarryingAmount Member2021-01-012021-06-300001771910IFRS-Full:Gross CarryingAmount MemberADC:許可InfiniteLivedMember2021-06-300001771910ADC:內部開發成本成員IFRS-Full:Gross CarryingAmount Member2021-06-300001771910ADC:許可定義實時成員IFRS-Full:Gross CarryingAmount Member2021-06-300001771910IFRS-FULL:計算機軟件成員IFRS-Full:Gross CarryingAmount Member2021-06-300001771910IFRS-Full:Gross CarryingAmount Member2021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC:許可InfiniteLivedMember2020-12-310001771910ADC:內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2020-12-310001771910ADC:許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2020-12-310001771910IFRS-FULL:計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2020-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2020-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC:許可InfiniteLivedMember2021-01-012021-06-300001771910ADC:內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-01-012021-06-300001771910ADC:許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-01-012021-06-300001771910IFRS-FULL:計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-01-012021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-01-012021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC:許可InfiniteLivedMember2021-06-300001771910ADC:內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-06-300001771910ADC:許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-06-300001771910IFRS-FULL:計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-06-300001771910ADC:許可InfiniteLivedMember2021-06-300001771910ADC:內部開發成本成員2021-06-300001771910ADC:許可定義實時成員2021-06-300001771910IFRS-FULL:計算機軟件成員2021-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2020-12-142020-12-14ADC:產品0001771910ADC:Overland ADCT BioPharmaCyLimited成員2021-12-310001771910ADC:Overland ADCT BioPharmaCyLimited成員2022-01-012022-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2022-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2020-12-310001771910ADC:Overland ADCT BioPharmaCyLimited成員2021-01-012021-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2021-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2022-04-012022-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2021-04-012021-06-300001771910國際財務報告準則-完整:建築業成員IFRS-Full:Gross CarryingAmount Member2021-12-310001771910IFRS-Full:Gross CarryingAmount MemberIFRS-Full:車輛成員2021-12-310001771910國際財務報告準則-完整:建築業成員IFRS-Full:Gross CarryingAmount Member2022-01-012022-06-300001771910IFRS-Full:Gross CarryingAmount MemberIFRS-Full:車輛成員2022-01-012022-06-300001771910國際財務報告準則-完整:建築業成員IFRS-Full:Gross CarryingAmount Member2022-06-300001771910IFRS-Full:Gross CarryingAmount MemberIFRS-Full:車輛成員2022-06-300001771910國際財務報告準則-完整:建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full:車輛成員2021-12-310001771910國際財務報告準則-完整:建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full:車輛成員2022-01-012022-06-300001771910國際財務報告準則-完整:建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full:車輛成員2022-06-300001771910國際財務報告準則-完整:建築業成員2022-06-300001771910IFRS-Full:車輛成員2022-06-300001771910國際財務報告準則-完整:建築業成員IFRS-Full:Gross CarryingAmount Member2020-12-310001771910IFRS-Full:Gross CarryingAmount MemberIFRS-Full:車輛成員2020-12-310001771910國際財務報告準則-完整:建築業成員IFRS-Full:Gross CarryingAmount Member2021-01-012021-06-300001771910IFRS-Full:Gross CarryingAmount MemberIFRS-Full:車輛成員2021-01-012021-06-300001771910國際財務報告準則-完整:建築業成員IFRS-Full:Gross CarryingAmount Member2021-06-300001771910IFRS-Full:Gross CarryingAmount MemberIFRS-Full:車輛成員2021-06-300001771910國際財務報告準則-完整:建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2020-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full:車輛成員2020-12-310001771910國際財務報告準則-完整:建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-01-012021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full:車輛成員2021-01-012021-06-300001771910國際財務報告準則-完整:建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full:車輛成員2021-06-300001771910國際財務報告準則-完整:建築業成員2021-06-300001771910IFRS-Full:車輛成員2021-06-30Utr:Sqm0001771910ADC:研究和開發費用成員2022-04-012022-06-300001771910ADC:研究和開發費用成員2021-04-012021-06-300001771910ADC:研究和開發費用成員2022-01-012022-06-300001771910ADC:研究和開發費用成員2021-01-012021-06-300001771910ADC:一般和行政費用成員2022-04-012022-06-300001771910ADC:一般和行政費用成員2021-04-012021-06-300001771910ADC:一般和行政費用成員2022-01-012022-06-300001771910ADC:一般和行政費用成員2021-01-012021-06-300001771910國際財務報告準則-完整:建築業成員2021-12-310001771910IFRS-Full:車輛成員2021-12-310001771910國際財務報告準則-完整:建築業成員2022-01-012022-06-300001771910IFRS-Full:車輛成員2022-01-012022-06-300001771910國際財務報告準則-完整:建築業成員2022-06-300001771910IFRS-Full:車輛成員2022-06-300001771910國際財務報告準則-完整:建築業成員2020-12-310001771910IFRS-Full:車輛成員2020-12-310001771910國際財務報告準則-完整:建築業成員2022-01-012022-03-310001771910IFRS-Full:車輛成員2022-01-012022-03-3100017719102022-01-012022-03-310001771910國際財務報告準則-完整:建築業成員2021-01-012021-06-300001771910IFRS-Full:車輛成員2021-01-012021-06-300001771910國際財務報告準則-完整:建築業成員2021-06-300001771910IFRS-Full:車輛成員2021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMember2020-04-240001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMember2020-04-242020-04-24ADC:借款組件0001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2020-04-240001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-04-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-01-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2021-04-012021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2021-01-012021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2021-12-310001771910ADC:InitialPublicOfferingMember2020-05-192020-05-190001771910IFRS-Full:編寫PutOptionsMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2022-06-300001771910IFRS-Full:編寫PutOptionsMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2021-12-310001771910ADC:ForcedConversionPriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2022-06-300001771910ADC:ForcedConversionPriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2021-12-310001771910ADC:SharePriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2022-06-300001771910ADC:SharePriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC:RiskFree InterestRateMemberIFRS-Full:衍生品成員2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC:RiskFree InterestRateMemberIFRS-Full:衍生品成員2021-12-310001771910ADC:預期數量成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2022-06-300001771910ADC:預期數量成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2021-12-310001771910ADC:預期術語成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2022-06-30ADC:句號0001771910ADC:預期術語成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC:DiviendYeldMembersIFRS-Full:衍生品成員2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC:DiviendYeldMembersIFRS-Full:衍生品成員2021-12-310001771910ADC:恢復率成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2022-06-300001771910ADC:恢復率成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2021-12-310001771910ADC:ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2022-06-300001771910ADC:ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full:衍生品成員2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-012021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-01-012021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full:TopOfRangeMember2020-04-242020-04-240001771910IFRS-Full:編寫PutOptionsMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full:衍生品成員2021-04-230001771910ADC:ForcedConversionPriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full:衍生品成員2021-04-230001771910ADC:SharePriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full:衍生品成員2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC:RiskFree InterestRateMemberIFRS-Full:衍生品成員2021-04-230001771910ADC:預期數量成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full:衍生品成員2021-04-230001771910ADC:預期術語成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full:衍生品成員2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC:DiviendYeldMembersIFRS-Full:衍生品成員2021-04-230001771910ADC:恢復率成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full:衍生品成員2021-04-230001771910ADC:ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full:衍生品成員2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2020-04-242020-04-240001771910IFRS-Full:編寫PutOptionsMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910IFRS-Full:編寫PutOptionsMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC:ForcedConversionPriceMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC:ForcedConversionPriceMember2021-04-230001771910ADC:SharePriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC:SharePriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC:RiskFree InterestRateMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC:RiskFree InterestRateMember2021-04-230001771910ADC:預期數量成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC:預期數量成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910ADC:預期術語成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC:預期術語成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC:DiviendYeldMembers2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC:DiviendYeldMembers2021-04-230001771910ADC:恢復率成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC:恢復率成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910ADC:ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC:ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-04-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-01-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMemberADC:ResidualLoanMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC:ResidualLoanMember2022-04-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC:ResidualLoanMember2022-01-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMemberADC:ResidualLoanMember2022-01-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC:ResidualLoanMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMemberADC:ResidualLoanMember2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC:ResidualLoanMember2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full:衍生品成員2021-01-012021-06-3000017719102021-06-04Xbrli:共享0001771910ADC:A2019股權激勵計劃成員2019-11-300001771910ADC:A2019股權激勵計劃成員2022-06-300001771910ADC:EmployeeStockOptionMember2021-03-222021-03-220001771910ADC:受限共享單位RSU成員2021-03-222021-03-220001771910ADC:EmployeeStockOptionMember2022-05-112022-05-110001771910ADC:A2019股權激勵計劃成員2022-01-012022-06-300001771910ADC:EmployeeStockOptionMember2022-04-012022-06-300001771910ADC:EmployeeStockOptionMember2022-01-012022-06-300001771910ADC:EmployeeStockOptionMember2021-04-012021-06-300001771910ADC:EmployeeStockOptionMember2021-01-012021-06-300001771910ADC:TrancheThreeMemberADC:EmployeeStockOptionMember2022-01-012022-06-300001771910ADC:TranscheTwoMembersADC:EmployeeStockOptionMember2022-01-012022-06-300001771910ADC:EmployeeStockOptionMemberADC:TranscheFourMembers2022-01-012022-06-300001771910ADC:TrancheOneMembersADC:EmployeeStockOptionMember2022-01-012022-06-300001771910ADC:EmployeeStockOptionMember2022-06-300001771910SRT:最小成員數2022-04-012022-06-300001771910SRT:最大成員數2022-04-012022-06-300001771910SRT:最小成員數2021-01-012021-06-300001771910SRT:最大成員數2021-01-012021-06-300001771910ADC:受限共享單位RSU成員2022-01-012022-06-300001771910ADC:Special RetentionAwardMemberADC:受限共享單位RSU成員2022-01-012022-06-300001771910ADC:Special RetentionAwardMemberADC:TrancheOneMembers2022-01-012022-06-300001771910ADC:TranscheTwoMembersADC:Special RetentionAwardMember2022-01-012022-06-300001771910ADC:受限共享單位RSU成員2022-04-012022-06-300001771910ADC:受限共享單位RSU成員2021-04-012021-06-300001771910ADC:受限共享單位RSU成員2021-01-012021-06-300001771910ADC:受限共享單位RSU成員2021-12-310001771910ADC:受限共享單位RSU成員2022-06-300001771910ADC:受限共享單位RSU成員ADC:年度股權獎成員2022-01-012022-06-300001771910ADC:EmployeeStockOptionMemberADC:A2019股權激勵計劃成員2022-04-012022-06-300001771910ADC:EmployeeStockOptionMemberADC:A2019股權激勵計劃成員2021-04-012021-06-300001771910ADC:EmployeeStockOptionMemberADC:A2019股權激勵計劃成員2022-01-012022-06-300001771910ADC:EmployeeStockOptionMemberADC:A2019股權激勵計劃成員2021-01-012021-06-300001771910ADC:受限的股票單位成員ADC:A2019股權激勵計劃成員2022-04-012022-06-300001771910ADC:受限的股票單位成員ADC:A2019股權激勵計劃成員2021-04-012021-06-300001771910ADC:受限的股票單位成員ADC:A2019股權激勵計劃成員2022-01-012022-06-300001771910ADC:受限的股票單位成員ADC:A2019股權激勵計劃成員2021-01-012021-06-300001771910ADC:獎勵計劃2014年成員2022-04-012022-06-300001771910ADC:獎勵計劃2014年成員2021-04-012021-06-300001771910ADC:獎勵計劃2014年成員2021-01-012021-06-3000017719102021-08-250001771910ADC:AuvenTreateuticsHoldingsLPM成員2022-01-012022-06-300001771910ADC:AuvenTreateuticsHoldingsLPM成員2022-04-012022-06-300001771910ADC:AuvenTreateuticsHoldingsLPM成員2021-04-012021-06-300001771910ADC:AuvenTreateuticsHoldingsLPM成員2021-01-012021-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2022-04-012022-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2022-01-012022-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2021-04-012021-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2021-01-012021-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2022-06-300001771910ADC:Overland ADCT BioPharmaCyLimited成員2021-12-310001771910Adc:A2019EquityIncentivePlanShareOptionsMember2022-04-012022-06-300001771910Adc:A2019EquityIncentivePlanShareOptionsMember2021-04-012021-06-300001771910Adc:A2019EquityIncentivePlanShareOptionsMember2022-01-012022-06-300001771910Adc:A2019EquityIncentivePlanShareOptionsMember2021-01-012021-06-300001771910ADC:A2019股權激勵計劃RSUsMembers2022-04-012022-06-300001771910ADC:A2019股權激勵計劃RSUsMembers2021-04-012021-06-300001771910ADC:A2019股權激勵計劃RSUsMembers2022-01-012022-06-300001771910ADC:A2019股權激勵計劃RSUsMembers2021-01-012021-06-300001771910Adc:ConvertibleLoansContingentlyIssuableSharesMember2022-04-012022-06-300001771910Adc:ConvertibleLoansContingentlyIssuableSharesMember2021-04-012021-06-300001771910Adc:ConvertibleLoansContingentlyIssuableSharesMember2022-01-012022-06-300001771910Adc:ConvertibleLoansContingentlyIssuableSharesMember2021-01-012021-06-300001771910ADC:獎勵計劃2014年成員2022-01-012022-06-300001771910ADC:獎勵計劃2014年成員2021-01-012021-06-300001771910ADC:許可協議成員2022-07-012022-07-310001771910ADC:應用程序批准成員2022-01-012022-01-31

美國
美國證券交易委員會
華盛頓特區,20549
表格6-K
外國私人發行人根據1934年《證券交易法》第13a-16條或15d-16條提交的報告
2022年8月
委託文件編號:001-39071
ADC治療公司
(註冊人的確切姓名載於其章程)
比奧波爾
科尼奇3B路
1066埃帕林吉斯
瑞士
(主要行政辦公室地址)
用複選標記表示註冊人是否在表格20-F或表格40-F的封面下提交或將提交年度報告:
表格20-F表格40-F
用複選標記表示註冊人是否按照S-T規則101(B)(1)所允許的紙質形式提交了表格6-K:
用複選標記表示註冊人是否按照S-T規則101(B)(7)所允許的紙質形式提交表格6-K:




以引用方式成立為法團
這份表格6-K的報告(本報告附件99.3除外),包括本報告的附件99.1和99.2,應被視為通過引用併入ADC Treateutics SA的表格F-3(註冊號333-256686和第333-256807)的註冊聲明,並自本報告提交之日起成為其中的一部分,但不得被隨後提交或提交的文件或報告所取代。


簽名
根據1934年《證券交易法》的要求,註冊人已正式促使本報告由正式授權的簽署人代表其簽署。
ADC治療公司
發信人:/s/詹妮弗·克里爾
姓名:詹妮弗·克里爾
標題:首席財務官
日期:2022年8月9日



展品索引
展品編號描述
99.1
截至2022年6月30日以及截至2022年6月30日的三個月和六個月的未經審計的IFRS綜合中期財務報表
99.2
管理層對財務狀況和經營成果的探討與分析
99.3
新聞稿日期:2022年8月9日
101.SCHXBRL分類擴展架構文檔
101.CALXBRL分類擴展計算鏈接庫文檔
101.DEFXBRL分類擴展定義Linkbase文檔
101.LABXBRL分類擴展標籤Linkbase文檔
101.PREXBRL分類擴展演示文稿Linkbase文檔
104封面交互數據文件(格式為內聯XBRL,包含在附件101中)